The Latest: Pfizer looks at vaccine with fewest side effects
|
August 20, 2020 12:03 PM
NEW YORK — Pfizer and its German partner BioNTech will take its COVID-19 vaccine candidate with the fewest side effects into final-stage testing.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
